CDSCO Guidance for Industry (Biologicals)
Guidance for industry (biologicals): clinical trial applications, new drug approval and quality information
Current edition
Version 1.2 (documents CT/032024, MA/032024 and QI/032024)
Current edition
Version 1.2 (documents CT/032024, MA/032024 and QI/032024)
About this standard
Sets the content of clinical trial and new drug applications for biological products in a five module common technical document layout, with detailed quality information for Module 3.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
India
- Biological products: common technical document layout and quality dossierDossier format · Sample testing
- Stability data for biological productsStability testing · Not stated
Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, JP notification on electronic study data (2024), M4(R4), M4Q(R1), M4Q(R2), M4S(R2), M4E(R2), ACTD, COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.